Elthera-led consortium initiates development of novel cancer diagnostics and therapeutics
November 24, 2020. Elthera AG, iCellate Medical AB, Targos GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of Kiel are proud to announce that they have received a non-dilutive grant with a total budget of 2.7 M € from the EUREKA Eurostars programme. The grant will allow the consortium to finalize the preclinical development of Elthera’s proprietary anti-L1CAM antibody and to develop novel L1CAM-based solid and liquid biopsy methods for patient selection and treatment monitoring in clinical trials.The consortium partners bring